A study to compare how the body absorbs and processes two different formulations of the anti-rejection medication tacrolimus (Advagraf® or Prograf®) in children receiving an organ transplant, and how safe and effective they are over a longer period of time

Trial Identifier: PMR-EC-1207
Sponsor: Astellas Pharma Europe Ltd.
Start Date: April 2012
Primary Completion Date: April 2021
Study Completion Date: April 2021
Condition: Kidney Transplants; Liver Transplants; Heart Transplants

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Czech Republic Prague 5, Czech Republic, 150 06
France Bron Cedex, France, 69677
France Paris Cedex 15, France
Italy Rome, Italy, 00165
Poland Warsaw, Poland, 04-730
United Kingdom Birmingham, United Kingdom, B4 6NH
United Kingdom Liverpool, United Kingdom, L12 2AP
United Kingdom London, United Kingdom, SE5 9RS
United Kingdom London, United Kingdom, WC1 3JH
United Kingdom Manchester, United Kingdom, M13 9WL